Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor.
5-F substitution of an aminothiazole moiety within a series of thrombopoietin receptor agonists leads to potent agents with an improved hepatic safety profile in rodent toxicology studies.